0.5062
Precedente Chiudi:
$0.4799
Aprire:
$0.4883
Volume 24 ore:
88,602
Relative Volume:
0.18
Capitalizzazione di mercato:
$27.03M
Reddito:
-
Utile/perdita netta:
$-151.16M
Rapporto P/E:
-0.1704
EPS:
-2.97
Flusso di cassa netto:
$-130.08M
1 W Prestazione:
+8.39%
1M Prestazione:
+10.12%
6M Prestazione:
-68.94%
1 anno Prestazione:
-92.39%
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Nome
Alx Oncology Holdings Inc
Settore
Industria
Telefono
650-466-7125
Indirizzo
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Confronta ALXO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ALXO
Alx Oncology Holdings Inc
|
0.5062 | 25.65M | 0 | -151.16M | -130.08M | -2.97 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-06 | Aggiornamento | Jefferies | Hold → Buy |
2024-12-19 | Downgrade | Jefferies | Buy → Hold |
2024-03-08 | Downgrade | Stifel | Buy → Hold |
2023-12-08 | Aggiornamento | Jefferies | Hold → Buy |
2021-12-22 | Downgrade | Jefferies | Buy → Hold |
2021-09-30 | Iniziato | Stifel | Buy |
2021-05-05 | Ripresa | Credit Suisse | Outperform |
2021-04-26 | Ripresa | Credit Suisse | Outperform |
2021-04-06 | Iniziato | UBS | Buy |
2021-02-10 | Iniziato | H.C. Wainwright | Buy |
2020-08-11 | Iniziato | Cantor Fitzgerald | Overweight |
2020-08-11 | Iniziato | Credit Suisse | Outperform |
2020-08-11 | Iniziato | Jefferies | Buy |
2020-08-11 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie
ALX Oncology Holdings Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional
Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
What analysts say about ALX Oncology Holdings Inc. stockOutstanding risk-reward balance - jammulinksnews.com
What drives ALX Oncology Holdings Inc. stock priceFree Wealth Management Insights - Autocar Professional
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
How ALX Oncology Holdings Inc. stock performs during market volatilitySwing Trade Signals - Newser
What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser
ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
ALX Oncology Confirms Directors at Annual Meeting - TipRanks
ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria
ALX Oncology reports annual meeting results - Investing.com
Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World
ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World
Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus
ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan
D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India
H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail
UBS Group Issues Pessimistic Forecast for ALX Oncology (NASDAQ:ALXO) Stock Price - Defense World
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Alx Oncology Holdings Inc Azioni (ALXO) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Pinto Shelly | SVP, FINANCE AND CAO |
Jun 30 '25 |
Sale |
0.43 |
1,532 |
659 |
88,820 |
Pinto Shelly | SVP, FINANCE AND CAO |
Feb 19 '25 |
Sale |
1.15 |
550 |
633 |
87,352 |
Pons Jaume | PRESIDENT & CSO |
Feb 19 '25 |
Sale |
1.15 |
1,326 |
1,525 |
579,388 |
Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Feb 19 '25 |
Sale |
1.15 |
2,159 |
2,483 |
170,270 |
Pinto Shelly | Interim CFO |
Jan 06 '25 |
Sale |
1.80 |
2,221 |
3,998 |
87,902 |
Pinto Shelly | Interim CFO |
Dec 30 '24 |
Sale |
1.58 |
1,426 |
2,253 |
90,123 |
Pons Jaume | PRESIDENT & CSO |
Dec 30 '24 |
Sale |
1.58 |
10,796 |
17,060 |
580,714 |
Hemrajani Rekha | Director |
Dec 02 '24 |
Buy |
1.55 |
30,000 |
46,404 |
33,000 |
Pinto Shelly | SVP, FINANCE AND CAO |
Aug 14 '24 |
Sale |
2.58 |
564 |
1,455 |
91,549 |
Randolph Sophia | CHIEF MEDICAL OFFICER |
Aug 14 '24 |
Sale |
2.58 |
1,365 |
3,522 |
325,711 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):